Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest announcement is out from Haoxi Health Technology Limited Class A ( (HAO) ).
Haoxi Health Technology Limited announced the details of its upcoming 2025 Annual General Meeting, which will be held in a hybrid format. Key proposals for the meeting include a share consolidation and an increase in authorized share capital, reflecting a strategic reorganization of the company’s share capital structure. Additionally, the company plans to adopt a new memorandum and articles of association and re-elect its current directors. The appointment of Wei, Wei & Co., LLP as independent auditors for the fiscal years ending in June 2024 and 2025 will also be ratified. These measures are aimed at strengthening Haoxi Health Technology’s operational and governance framework, potentially enhancing its market position and shareholder value.
More about Haoxi Health Technology Limited Class A
Haoxi Health Technology Limited is a company in the health technology sector, primarily focused on developing innovative health solutions. The company’s market focus includes providing advanced health technology products and services that cater to the growing demands of the healthcare industry.
YTD Price Performance: -97.63%
Average Trading Volume: 6,975,289
Technical Sentiment Consensus Rating: Strong Buy
See more data about HAO stock on TipRanks’ Stock Analysis page.
